Ipsen (FR:IPN) has released an update.
Ipsen, a global biopharmaceutical company, has announced the appointment of Josep Catllà as its new Executive Vice President, Chief Corporate Affairs Officer, effective August 19, 2024. Catllà, with 30 years of experience in communications, public affairs, and government relations, joins from Sanofi and is poised to enhance Ipsen’s strategic vision, employee engagement, and stakeholder partnerships. His predecessor, Gwenan White, is departing to pursue new opportunities, and CEO David Loew has expressed high expectations for Catllà’s contributions to the company’s mission.
For further insights into FR:IPN stock, check out TipRanks’ Stock Analysis page.
